High Sustained Virologic Response Rates in Patients Infected With HCV genotype 2 With Baseline NS5A Polymorphisms Treated With Daclatasvir-Based Regimens

Conference Reports for NATAP

The International Liver Congress™
EASL - European Association for the
Study of the Liver
Barcelona, Spain
13-17 April 2016


High Sustained Virologic Response Rates in Patients Infected With HCV genotype 2 With Baseline NS5A Polymorphisms Treated With Daclatasvir-Based Regimens

	Reported by Jules Levin EASL 2016 April 14-17 Barcelona